Stephen Bloch, MD


Dr. Bloch is a General Partner at Canaan Partners. As an early investor and chairman, Dr. Bloch helped Advanced BioHealing (ABH), a leader in regenerative medicine, grow from a seed-stage company to a $750 million all-cash acquisition by Shire. He currently serves on the boards of companies in healthcare IT (Truveris and Ambra Health); biopharma (Envisia and Liquidia); medical devices (Mitraspan); and diagnostics (Sample6). Before joining Canaan in 2002, Dr. Bloch founded multiple start-ups, including Radiology Management Sciences (RMS), a specialty medical management company, where he was CEO for 6 years. Dr. Bloch obtained his B.A. from Dartmouth College, received his M.A. in the history of science and public policy from Harvard, and he earned his medical degree from the University of Rochester. Dr. Bloch received his medical training at Massachusetts General Hospital/Harvard Medical School (radiology) and Lenox Hill Hospital/Cornell Medical School (internal medicine).

Chairman of the Board